TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 51 filers reported holding TCR2 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 20.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $84,000 | -56.9% | 29,030 | -30.8% | 0.00% | -100.0% |
| Q4 2021 | $195,000 | +41.3% | 41,925 | +158.0% | 0.00% | – |
| Q3 2021 | $138,000 | -93.9% | 16,247 | -88.1% | 0.00% | -100.0% |
| Q2 2021 | $2,247,000 | +18.5% | 136,902 | +59.3% | 0.01% | -18.2% |
| Q1 2021 | $1,897,000 | +204.5% | 85,926 | +326.3% | 0.01% | +120.0% |
| Q4 2020 | $623,000 | +213.1% | 20,154 | +44.6% | 0.01% | +400.0% |
| Q4 2019 | $199,000 | – | 13,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |